Arkolith/Insider Trading/ARTH/Form 4

Norchi Terrence W

PRESIDENT AND CHIEF EXECUTIVEArch Therapeutics, Inc. (ARTH) · full profile →Form 4 · filed Jul 8, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 6, 2022Grant(A)72K——3.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 6, 2022Grant(A)483K——483K
Jul 6, 2022Grant(A)0———

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-22-007596) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML